| Structure |
Chemical Name |
CAS |
MF |
 |
Flomoxef Impurity 5 |
134237-56-2 |
C25H23ClF2N2O6S |
 |
Ranitidine impurity |
94167-82-5 |
C10H18N2O |
 |
nicergoline impurity E |
|
|
 |
Tacrolimus Impurity C |
|
|
 |
Levodopa impurity 5 |
|
|
![(R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide](/CAS/20180629/GIF/1223404-68-9.gif) |
(R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide |
1223404-68-9 |
C21H22F2N6O2 |
 |
Ivabradine Impurity 1 Hydrochloride |
85175-52-6 |
C16H25ClN2O3 |
 |
SofosBuvir Impurity 3 |
|
|
 |
Canagliflozin Impurity 10 |
1672658-93-3 |
C24H25FO6S |
 |
Canagliflozin Impurity F |
|
|
 |
Empagliflozin impurity E |
|
|
 |
Fasudil Impurity 6 |
2044706-58-1 |
C11H11NO3S |
 |
Ibrutinib Impurity 11 |
|
C27H31N7O2 |
 |
Nintedanib impurity I |
334951-61-0 |
C30H31N5O4 |
 |
(Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylic acid compound with 3-benzoyl-2-oxoindoline-6-carboxylic acid |
1253768-91-0 |
C16H11NO4 |
 |
Everolimus Related Compound 3 |
147438-30-0 |
C32H49NO9 |
 |
(R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate |
1627824-09-2 |
C18H17F5NO5P |
 |
Cefuroxime Sodium EP Impurity C |
69822-88-4 |
C15H15N3O6S |
 |
Amphotericin X1 (13-O-Methyl Amphotericin B) |
136135-57-4 |
C48H75NO17 |
 |
Salbutamol Impurity 40 |
|
|
![Benzeneethanamine, N-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxy-](/CAS/20210305/GIF/24997-88-4.gif) |
Benzeneethanamine, N-[2-(3,4-dimethoxyphenyl)ethyl]-3,4-dimethoxy- |
24997-88-4 |
C20H27NO4 |
![Acetamide, N-[4-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-](/CAS/20210305/GIF/871701-23-4.gif) |
Acetamide, N-[4-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]- |
871701-23-4 |
C26H23FIN5O4 |
 |
Deiodo Trametinib |
871700-65-1 |
C26H24FN5O4 |
 |
4-(4-メトキシフェニル)-3-ブテン-2-オン |
943-88-4 |
C11H12O2 |
![Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)imino]-3,4,5,6,7,8-hexahydro-8-hydroxy-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]-](/CAS/20210305/GIF/1383430-03-2.gif) |
Acetamide, N-[3-[3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)imino]-3,4,5,6,7,8-hexahydro-8-hydroxy-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]- |
1383430-03-2 |
C26H23FIN5O5 |
 |
2-(2-Fluoro-4-iodo-aniline)-4-hydroxy-1, 5-dimethyl-6-oxo-1,6-dihydro-pyridine-3-carboxylic acid cyclopropylamide |
3018911-27-5 |
C17H17FIN3O3 |
 |
サルブタモールアセトニド |
54208-72-9 |
C16H25NO3 |
![Pyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione, 1-(3-aminophenyl)-3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-](/CAS/GIF/871701-87-0.gif) |
Pyrido[4,3-d]pyrimidine-2,4,7(1H,3H,6H)-trione, 1-(3-aminophenyl)-3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl- |
871701-87-0 |
C24H21FIN5O3 |
 |
Dobutamine Impurity 15 |
|
|
 |
L-Proline, 5-oxo-, compd. with chitosan |
117522-93-7 |
|
 |
N-nitroso-desmethyl-Clemastine |
|
|
 |
Cefuroxime Sodium EP Impurity G |
97232-98-9 |
C17H17N3O8S |
 |
2-chloro-4-(cyclopentylamino)-5-pyrimidinyl ethanone |
1244949-62-9 |
C11H14ClN3O |
 |
Losartan Impurity 7 |
358685-13-9 |
C33H24Br2N4 |
 |
Salbutamol impurity 41 |
|
|
![[1,1'-Biphenyl]-3,3'-dicarboxamide, 6,6'-diamino-5-chloro-N3,N3'-bis[2-(diethylamino)ethyl]-2,4'-dimethoxy-](/CAS/20210305/GIF/1242047-99-9.gif) |
[1,1'-Biphenyl]-3,3'-dicarboxamide, 6,6'-diamino-5-chloro-N3,N3'-bis[2-(diethylamino)ethyl]-2,4'-dimethoxy- |
1242047-99-9 |
C28H43ClN6O4 |
![6-(4-{2-[3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-2-methyl-heptan-2-ol](/CAS/GIF/140710-96-9.gif) |
6-(4-{2-[3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohexylidene]-ethylidene}-7a-methyl-octahydro-inden-1-yl)-2-methyl-heptan-2-ol |
140710-96-9 |
C39H72O3Si2 |
 |
DOXYCYCLINE RELATED COMPOUND A ((4S,4AR,5S,5AR,6S,12AS)-4-(ジメチルアミノ)-1,4,4A,5,5A,6,11,12A-オクタヒドロ-3,5,10,12,12A-ペンタヒドロキシ-6-メチル-1,11-ジオキソ-2-ナフタセンカル |
3219-99-6 |
C22H24N2O8 |
![3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione](/CAS/GIF/871700-24-2.gif) |
3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione |
871700-24-2 |
C18H15FIN3O4 |
 |
Salbutamol Impurity 38 |
|
|
![安息香酸3-[7-シアノ-5-[(2R)-2-[[2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチル]アミノ]プロピル]インドリン-1-イル]プロピル](/CAS/GIF/885340-11-4.gif) |
安息香酸3-[7-シアノ-5-[(2R)-2-[[2-[2-(2,2,2-トリフルオロエトキシ)フェノキシ]エチル]アミノ]プロピル]インドリン-1-イル]プロピル |
885340-11-4 |
C32H34F3N3O4 |
 |
Dobutamine Impurity 16 |
|
|
![Benzamide, 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-[3-fluoro-4-[(methylamino)carbonyl]phenyl]-N-methyl-](/CAS/20210305/GIF/2894796-76-8.gif) |
Benzamide, 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-[3-fluoro-4-[(methylamino)carbonyl]phenyl]-N-methyl- |
2894796-76-8 |
C29H21F5N6O3S |
![1-(6-メトキシ-1H-ベンゾ[D]イミダゾール-2-イル)-3,5-ジメチル-4-オキソ-1,4-ジヒドロピリジン-2-カルボン酸](/CAS/20150408/GIF/1227380-90-6.gif) |
1-(6-メトキシ-1H-ベンゾ[D]イミダゾール-2-イル)-3,5-ジメチル-4-オキソ-1,4-ジヒドロピリジン-2-カルボン酸 |
1227380-90-6 |
C16H15N3O4 |
![4H-Inden-4-one, 1-[1,5-dimethyl-5-[(triethylsilyl)oxy]hexyl]octahydro-7a-methyl-, [1R-[1α(R*),3aβ,7aα]]-](/CAS/20180808/GIF/144848-24-8.gif) |
4H-Inden-4-one, 1-[1,5-dimethyl-5-[(triethylsilyl)oxy]hexyl]octahydro-7a-methyl-, [1R-[1α(R*),3aβ,7aα]]- |
144848-24-8 |
C24H46O2Si |
 |
Salbutamol Impurity 37 |
|
|
 |
Dobutamine Impurity 3 |
334947-75-0 |
C19H25NO3 |
![1H-?Indole-?5,?6-?diol, 1-?[3-?(4-?hydroxyphenyl)?-?1-?methylpropyl]?-](/CAS/20210111/GIF/2514709-72-7.gif) |
1H-?Indole-?5,?6-?diol, 1-?[3-?(4-?hydroxyphenyl)?-?1-?methylpropyl]?- |
2514709-72-7 |
C18H19NO3 |
 |
Iguratimod Impurity 9 |
1179354-65-4 |
C18H16N2O6S |
![[R,(+)]-2,4-ジヒドロキシ-3,3-ジメチル酪酸ナトリウム](/CAS/GIF/60979-68-2.gif) |
[R,(+)]-2,4-ジヒドロキシ-3,3-ジメチル酪酸ナトリウム |
60979-68-2 |
C{6}H{11}NaO{4} |
 |
Salbutamol impurity 42 |
18910-69-5 |
C14H23NO3 |
 |
Vancomycin Impurity J |
2416251-24-4 |
C66H75Cl2N9O24 |
 |
LS01-I01 |
|
|
 |
クロロクリプチン |
68944-88-7 |
C32H40ClN5O5 |
![4-メチルベンゼンスルホン酸3-シクロプロピル-1-(2-フルオロ-4-ヨードフェニル)-6,8-ジメチル-2,4,7-トリオキソ-1,2,3,4,7,8-ヘキサヒドロピリド[2,3-D]ピリミジン-5-イル](/CAS/GIF/871700-32-2.gif) |
4-メチルベンゼンスルホン酸3-シクロプロピル-1-(2-フルオロ-4-ヨードフェニル)-6,8-ジメチル-2,4,7-トリオキソ-1,2,3,4,7,8-ヘキサヒドロピリド[2,3-D]ピリミジン-5-イル |
871700-32-2 |
C25H21FIN3O6S |
 |
1-(chloromethyl)-2-trifluoromethyl-4-methylbenzene |
1261456-37-4 |
C9H8ClF3 |
 |
2-Debenzoyl-2-pentenoyl Docetaxel |
1412898-66-8 |
C41H55NO14 |
 |
O-descarbonyl O-Acetyl Linezolid |
333753-71-2 |
C15H22FN3O3 |
 |
Soradespa Impurity |
851528-83-1 |
C23H27F3O5S |
![6-(1-Cyclopropyl-1H-pyrazol-4-yl)-3-[difluoro(6-fluoro-2H-indazol-5-yl)methyl]-1,2,4-triazolo[4,3-b]pyridazine](/CAS/20210305/GIF/1440964-95-3.gif) |
6-(1-Cyclopropyl-1H-pyrazol-4-yl)-3-[difluoro(6-fluoro-2H-indazol-5-yl)methyl]-1,2,4-triazolo[4,3-b]pyridazine |
1440964-95-3 |
C19H13F3N8 |
 |
SALVIAMILTIORRHIZA |
|
|
![4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-3-sulfonamide](/) |
4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-3-sulfonamide |
|
|
![ForMaMide, N-[5-(2R)-oxiranyl-2-(phenylMethoxy)phenyl]-](/CAS/GIF/201677-57-8.gif) |
ForMaMide, N-[5-(2R)-oxiranyl-2-(phenylMethoxy)phenyl]- |
201677-57-8 |
C16H15NO3 |
 |
Baricitinib Impurity 1 |
2964606-44-6 |
C15H15N7O2S |
![1-benzyl-4-hydroxy-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid](/CAS/20200119/GIF/1640981-19-6.gif) |
1-benzyl-4-hydroxy-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid |
1640981-19-6 |
C16H14N2O3 |
 |
Methyl 6-chloro-2-naphthoate |
5042-96-6 |
C12H9ClO2 |
 |
(3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-yl acetate |
2875066-46-7 |
C16H17F5O4 |
 |
(2R,3S)-2-(4-(N-cyclopentyl-2-fluoro-6-methylbenzamido)phenyl)-1-(2-fluoro-6-methylbenzoyl)-N-(4-methyl-3-(trifluoromethyl)phenyl)piperidine-3-carboxamide |
|
|
 |
Apalutamide Acid Impurity |
1332391-04-4 |
C20H12F4N4O3S |
 |
2-クロロ-1,3-ジニトロベンゼン |
606-21-3 |
C6H3ClN2O4 |
 |
Cefixime Polymer Impurity B |
|
|
![3-Azetidineacetic acid, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-, methyl ester](/CAS/20210305/GIF/2402776-80-9.gif) |
3-Azetidineacetic acid, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-, methyl ester |
2402776-80-9 |
C17H20N6O4S |
 |
Dotinurad Impurity 22 |
2142685-21-8 |
C15H14N2S2 |
 |
Vonoprazan Trimer Impurity |
|
|
 |
(1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)cyclopropanecarboxylic acid |
1369769-35-6 |
C17H17FN2O3 |
![(9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime]](/CAS/GIF/425365-64-6.gif) |
(9E)-Erythromycin 9-[O-[[(2-Methoxyethoxy)methoxy]methyl]oxime] |
425365-64-6 |
C42H78N2O16 |
![3,3'-((2,2'-bis(ethoxymethyl)-[1,1'-biphenyl]-4,4'-diyl)bis(methylene))bis(2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one)](/) |
3,3'-((2,2'-bis(ethoxymethyl)-[1,1'-biphenyl]-4,4'-diyl)bis(methylene))bis(2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one) |
|
|
![4-(6-((6-ブロモ-8-シクロペンチル-5-メチル-7-オキソ-7,8-ジヒドロピリド[2,3-D]ピリミジン-2-イル)アミノ)ピリジン-3-イル)ピペラジン-1-カルボン酸TERT-ブチル](/StructureFile/ChemBookStructure22/GIF/CB61010565.gif) |
4-(6-((6-ブロモ-8-シクロペンチル-5-メチル-7-オキソ-7,8-ジヒドロピリド[2,3-D]ピリミジン-2-イル)アミノ)ピリジン-3-イル)ピペラジン-1-カルボン酸TERT-ブチル |
571188-82-4 |
C27H34BrN7O3 |
![Benzoic acid, 4-[(2S,4S)-4-hydroxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]-](/CAS/20240320/GIF/1644670-02-9.gif) |
Benzoic acid, 4-[(2S,4S)-4-hydroxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]- |
1644670-02-9 |
C23H26N2O4 |
![[1,1′-Biphenyl]-2-sulfonamide, 4′-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2′-(hydroxymethyl)-](/CAS/20240320/GIF/254740-63-1.gif) |
[1,1′-Biphenyl]-2-sulfonamide, 4′-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2′-(hydroxymethyl)- |
254740-63-1 |
C30H36N4O5S |
![Benzoic acid, 4-[(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]-, ethyl ester](/CAS/20250703/GIF/1644670-76-7.gif) |
Benzoic acid, 4-[(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]-, ethyl ester |
1644670-76-7 |
C27H34N2O4 |
![3,5-Pyridinedicarboxylic acid, 2-[(2-chloroethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester](/CAS/20210305/GIF/221446-45-3.gif) |
3,5-Pyridinedicarboxylic acid, 2-[(2-chloroethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester |
221446-45-3 |
C20H23Cl2NO5 |
 |
γ-Cyclodextrin, 6A,6B,6C,6D,6E,6F,6G-heptabromo-6A,6B,6C,6D,6E,6F,6G-heptadeoxy- |
2458187-21-6 |
C48H73Br7O33 |
![N-[[7-(AMINOSULFONYL)-6-CHLORO-2,3-DIHYDRO-1,1-DIOXO-4H-1,2,4-BENZOTHIADIAZIN-4-YL]METHYL]-6-CHLORO-3,4-DIHYDRO-1,1-DIOXO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDEヒドロクロロチアジ](/CAS/GIF/402824-96-8.gif) |
N-[[7-(AMINOSULFONYL)-6-CHLORO-2,3-DIHYDRO-1,1-DIOXO-4H-1,2,4-BENZOTHIADIAZIN-4-YL]METHYL]-6-CHLORO-3,4-DIHYDRO-1,1-DIOXO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDEヒドロクロロチアジ |
402824-96-8 |
C15H16Cl2N6O8S4 |
 |
(3S.4S.5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-yl acetate |
3041980-36-0 |
C14H15F5O3 |
 |
(S,E)-3-(2,6-dichloro-4-((4-(3-(1-(hexyloxy)ethyl)-2-hydroxyphenyl)thiazol-2-yl)carbamoyl)phenyl)-2-methylacrylic acid |
|
|
![N-(3-{[(4-methylphenyl)sulfonyl]amino}phenyl)acetamide](/CAS/20180601/GIF/329941-39-1.gif) |
N-(3-{[(4-methylphenyl)sulfonyl]amino}phenyl)acetamide |
329941-39-1 |
C15H16N2O3S |
 |
Baricitinib Impurity 6 |
2166596-69-4 |
C12H19N3O2Si |
 |
DMT-2'-O-4'-C-Locked-G(iBu)-CE |
|
|
![4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-4-sulfonamide](/) |
4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-4-sulfonamide |
|
|
 |
(2S,3R,4R,5S,6R)-2-(4-bromo-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol |
|
|
 |
N-(3-(6-acrylamido-5-(2-(N-methylacrylamido)ethoxy)pyrimidin-4-yl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide |
|
|
 |
Paris polyphylla |
|
|
 |
Dapoxetine Impurity 11 |
151649-29-5 |
C19H16O |
 |
4-(クロロメチル)ベンジルアルコール |
16473-35-1 |
C8H9ClO |
![Cyclopropanecarboxaldehyde, 2-[[(2,4-dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-, (1R,2S)-](/CAS/20210305/GIF/1369767-26-9.gif) |
Cyclopropanecarboxaldehyde, 2-[[(2,4-dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-, (1R,2S)- |
1369767-26-9 |
C17H17FN2O2 |
![Benzoic acid, 4-[(2S,4S)-4-ethoxy-2-piperidinyl]-](/CAS/20240320/GIF/3040999-15-0.gif) |
Benzoic acid, 4-[(2S,4S)-4-ethoxy-2-piperidinyl]- |
3040999-15-0 |
C14H19NO3 |
 |
Amlodipine Impurity 27 |
2832589-38-3 |
C26H29ClN2O7S |
 |
(5R)-ethyl 5-((1R,3aS,7aR)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldiMethylsilyloxy)-2-Methylenecyclohexylidene)ethyl)-7a-Methyloctahydro-1H-inden-1-yl)hexanoate |
169900-32-7 |
C39H70O4Si2 |
![(2R,5S,13aR)-8-methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide](/CAS/20180703/GIF/1616340-94-3.gif) |
(2R,5S,13aR)-8-methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide |
1616340-94-3 |
C22H20F3N3O5 |